Carfilzomib nanoparticle - HunLife Biotechnology
Alternative Names: HuL-002; Lactosome-CFZ nanoparticle - HunLife BiotechnologyLatest Information Update: 02 Oct 2021
At a glance
- Originator HuniLife Biotechnology
- Class Antineoplastics; Epoxy compounds; Oligopeptides; Small molecules
- Mechanism of Action Proteasome inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Multiple myeloma
Most Recent Events
- 16 Sep 2020 Preclinical trials in Multiple myeloma in Taiwan (unspecified route), before September 2020 (HuniLife Biotechnology pipeline, September 2020)